newsfilter
← Latest News
GlobeNewswire·

KemPharm, Inc. Announces Authorization of $50 Million Share Repurchase Program

CELEBRATION, Fla., Dec. 20, 2021 (GLOBE NEWSWIRE) -- KemPharm, Inc. (NASDAQ:KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced today its Board of Directors has authorized a program to